Gardiner Sandra A.
SEC-identified person · CIK 1218574 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Adagio Medical Holdings, Inc. ADGM | Director | filed 2024–2025 |
| Kronos Bio, Inc. KRON | Interim CFO | filed 2023–2023 |
| Nektar Therapeutics NKTR | Chief Financial Officer | filed 2023–2023 |
| Anebulo Pharmaceuticals, Inc. ANEB | Acting Chief Financial Officer | filed 2023–2023 |
| Lucira Health, Inc. LHDX | Director | filed 2021–2022 |
| Pulse Biosciences, Inc. PLSE | CFO & EVP Admin. and Finance | filed 2019–2022 |
| Cutera INC CUTR | EVP & Chief Financial Officer | filed 2017–2019 |
| Vermillion, INC. vrml | VP & Chief Financial Officer | filed 2010–2011 |
| Lipid Sciences INC/ LIPD | Chief Financial Officer | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.